Morgan Stanley’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $246M | Sell |
|
|||||
|
2025
Q1 | $272M | Buy |
|
|||||
|
2024
Q4 | $273M | Sell |
|
|||||
|
2024
Q3 | $366M | Buy |
|
|||||
|
2024
Q2 | $372M | Sell |
|
|||||
|
2024
Q1 | $367M | Sell |
|
|||||
|
2023
Q4 | $817M | Buy |
|
|||||
|
2023
Q3 | $384M | Buy |
|
|||||
|
2023
Q2 | $408M | Buy |
|
|||||
|
2023
Q1 | $363M | Sell |
|
|||||
|
2022
Q4 | $394M | Buy |
|
|||||
|
2022
Q3 | $332M | Sell |
|
|||||
|
2022
Q2 | $281M | Buy |
|
|||||
|
2022
Q1 | $201M | Buy |
|
|||||
|
2021
Q4 | $187M | Buy |
|
|||||
|
2021
Q3 | $213M | Buy |
|
|||||
|
2021
Q2 | $243M | Buy |
|
|||||
|
2021
Q1 | $173M | Sell |
|
|||||
|
2020
Q4 | $190M | Buy |
|
|||||
|
2020
Q3 | $197M | Buy |
|
|||||
|
2020
Q2 | $101M | Buy |
|
|||||
|
2020
Q1 | $118M | Sell |
|
|||||
|
2019
Q4 | $126M | Sell |
|
|||||
|
2019
Q3 | $154M | Buy |
|
|||||
|
2019
Q2 | $117M | Sell |
|
|||||
|
2019
Q1 | $228M | Sell |
|
|||||
|
2018
Q4 | $305M | Buy |
|
|||||
|
2018
Q3 | $345M | Sell |
|
|||||
|
2018
Q2 | $508M | Buy |
|
|||||
|
2018
Q1 | $298M | Sell |
|
|||||
|
2017
Q4 | $349M | Sell |
|
|||||
|
2017
Q3 | $344M | Buy |
|
|||||
|
2017
Q2 | $293M | Buy |
|
|||||
|
2017
Q1 | $264M | Sell |
|
|||||
|
2016
Q4 | $274M | Sell |
|
|||||
|
2016
Q3 | $318M | Buy |
|
|||||
|
2016
Q2 | $241M | Sell |
|
|||||
|
2016
Q1 | $280M | Sell |
|
|||||
|
2015
Q4 | $380M | Sell |
|
|||||
|
2015
Q3 | $387M | Buy |
|
|||||
|
2015
Q2 | $524M | Sell |
|
|||||
|
2015
Q1 | $556M | Sell |
|
|||||
|
2014
Q4 | $532M | Buy |
|
|||||
|
2014
Q3 | $416M | Buy |
|
|||||
|
2014
Q2 | $295M | Buy |
|
|||||
|
2014
Q1 | $244M | Sell |
|
|||||
|
2013
Q4 | $224M | Buy |
|
|||||
|
2013
Q3 | $99.1M | Sell |
|
|||||
|
2013
Q2 | $125M | Buy |
|